T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
Open Access
- 1 February 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 124 (2) , 851-854
- https://doi.org/10.4049/jimmunol.124.2.851
Abstract
These studies demonstrate that two different types of protective immunologic reactions are generated in mice after inoculation with M.MSV. Type I protection, mediated by Ly1 cells, prevents MSV-induced sarcomas but has no effect on the growth of MLV+ lymphomas. This anti-MSV protection reflects induction of antivirion antibody and delayed type hypersensitivity reaction. Type II protection is mediated by Ly23 cells and prevents the growth of an MLV+ lymphoma, but has little or no protective effects against MSV-induced sarcomas. This "type II" reaction is directly related to CTL activity. The implications of these two protective reaction are discussed.This publication has 7 references indexed in Scilit:
- T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.The Journal of Immunology, 1980
- Cell-surface antigens induced by RNA tumour virusesNature, 1979
- Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses.The Journal of Experimental Medicine, 1976
- Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression.The Journal of Experimental Medicine, 1976
- Some Biologic, Immunogenic, and Morphologic Effects in Mice After Infection With a Murine Sarcoma Virus. I. Biologic and Immunogenic StudiesJNCI Journal of the National Cancer Institute, 1968
- ANTIGENICITY OF A VIRUS-INDUCED MURINE SARCOMA (MOLONEY)1967
- Pathogenesis of a Virus-Induced Rhabdomyosarcoma in MiceJNCI Journal of the National Cancer Institute, 1966